Cargando…
Virtual Screening of Specific Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors from the National Cancer Institute (NCI) Molecular Database
Insulin-like growth factor 1 receptor (IGF1R) is an attractive drug target for cancer therapy and research on IGF1R inhibitors has had success in clinical trials. A particular challenge in the development of specific IGF1R inhibitors is interference from insulin receptor (IR), which has a nearly ide...
Autores principales: | Fan, Cong, Huang, Yan-Xin, Bao, Yong-Li, Sun, Lu-Guo, Wu, Yin, Yu, Chun-Lei, Zhang, Yu, Song, Zhen-Bo, Zheng, Li-Hua, Sun, Ying, Wang, Guan-Nan, Li, Yu-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546745/ https://www.ncbi.nlm.nih.gov/pubmed/23242155 http://dx.doi.org/10.3390/ijms131217185 |
Ejemplares similares
-
Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes
por: Gao, Xiu Kui, et al.
Publicado: (2022) -
Receptor-Based Virtual Screening of EGFR Kinase Inhibitors from the NCI Diversity Database
por: Choowongkomon, Kiattawee, et al.
Publicado: (2010) -
Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis
por: Haji, Naemah, et al.
Publicado: (2023) -
National Cancer Institute (NCI) Program for Natural
Products Discovery: Rapid Isolation and Identification of Biologically
Active Natural Products from the NCI Prefractionated Library
por: Grkovic, Tanja, et al.
Publicado: (2020) -
National Cancer
Institute (NCI) Program for Natural
Product Discovery: Exploring NCI-60 Screening Data of Natural Product
Samples with Artificial Neural Networks
por: Evans, Jason R., et al.
Publicado: (2023)